IRON - Disc Medicine, Inc.
NEXT EARNINGS:
Feb 26, 2026
(in 13 days)
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$122.80
DETAILS
HIGH:
$153.00
LOW:
$110.00
MEDIAN:
$117.00
CONSENSUS:
$122.80
UPSIDE:
108.74%
Market Cap:
2.22B
Volume:
4,984,522
Avg Volume:
581,350
52 Week Range:
30.82-99.5
Sector:
Healthcare
Industry:
Biotechnology
Beta:
2.58
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
94
IPO Date:
2020-08-12
EPS (TTM):
-3.96
P/E Ratio:
-16.00
Revenue (TTM):
N/A
Total Assets:
496.77M
Total Debt:
30.00M
Cash & Equiv:
192.43M
Rev Growth (5Y):
N/A
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-22.9%
Debt/Equity:
0.07
Track Record
Statements >| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Net Income | (109.36M) | (76.43M) | (46.83M) | (35.97M) | (40.84M) |
| EPS | -3.96 | -3.42 | -45.05 | -44.88 | -27.02 |
| Total Assets | 496.77M | 368.00M | 200.21M | 92.41M | 8.32M |
| Total Debt | 30.00M | 2.10M | 1.33M | 7.06M | 21.64M |
| Cash & Equivalents | 192.43M | 360.38M | 194.61M | 88.04M | 4.50M |
| Operating Cash Flow | (93.93M) | (73.46M) | (42.25M) | (27.53M) | (32.71M) |
| Free Cash Flow | (94.43M) | (73.55M) | (42.40M) | (27.60M) | (32.73M) |
| FCF per Share | -3.42 | -3.30 | -40.79 | -34.44 | -21.65 |
| Book Value | 443.59M | 345.12M | 176.60M | (64.20M) | (21.86M) |
| Cash & ST Investments | 489.88M | 360.38M | 194.61M | 88.04M | 4.50M |
| ROC Equity | -0.25 | -0.22 | -0.27 | N/A | N/A |